Suppr超能文献

从上下文特异性肽展示噬菌体文库中筛选用于腺病毒载体靶向的肌肉结合肽。

Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting.

作者信息

Ghosh Debadyuti, Barry Michael A

机构信息

Center for Cell and Gene Therapy, The Methodist Hospital Texas Children's Hospital, One Baylor Plaza, BCM505, Houston, TX 77030, USA.

出版信息

J Virol. 2005 Nov;79(21):13667-72. doi: 10.1128/JVI.79.21.13667-13672.2005.

Abstract

Production of cell-targeting vectors in part involves the addition of new targeting ligands to the vector to mediate binding to the cells of interest. For viral vectors, the ideal approach is to genetically engineer new ligands into the capsid proteins of the virus to generate a single agent to mediate therapy. Although this is ideal, this insertion of an exogenous ligand from one structural context into the differing structural context of a capsid protein can ablate the function of the ligand or disrupt viral assembly and function. To address this context problem for adenoviral vectors, we have engineered a "context-specific" peptide-presenting phage library. We have displayed a 12-amino-acid (12-mer) random peptide library between the H and I sheets of the fiber protein of adenovirus type 5 on the pIII protein of fd bacteriophage. This library was used for peptide selection against C2C12 mouse skeletal muscle cells. Five rounds of selection combined with four rounds of clearing on nontarget cells selected one primary peptide designated 12.51, which bound target C2C12 cells approximately 100-fold better than the positive control RGD peptide. Translation of 12.51 back into the fiber protein produced a ligand-modified adenoviral vector that mediated 14-fold-better transduction of target C2C12 cells. These data suggest context-specific peptide-presenting libraries may allow selection of compatible peptide ligands for functional translation into viral vectors for retargeting.

摘要

细胞靶向载体的生产部分涉及向载体添加新的靶向配体,以介导与感兴趣细胞的结合。对于病毒载体,理想的方法是将新的配体基因工程改造到病毒的衣壳蛋白中,以生成单一的治疗介质。虽然这很理想,但将来自一种结构背景的外源配体插入衣壳蛋白不同的结构背景中,可能会消除配体的功能或破坏病毒组装及功能。为了解决腺病毒载体的这种背景问题,我们构建了一个“背景特异性”肽展示噬菌体文库。我们在fd噬菌体的pIII蛋白上,于5型腺病毒纤维蛋白的H和I片层之间展示了一个12个氨基酸(12肽)的随机肽文库。该文库用于针对C2C12小鼠骨骼肌细胞进行肽筛选。经过五轮筛选以及对非靶细胞进行四轮清除,筛选出一种名为12.51的主要肽,其与靶标C2C12细胞的结合能力比阳性对照RGD肽强约100倍。将12.51回译到纤维蛋白中产生了一种配体修饰的腺病毒载体,其介导的靶标C2C12细胞转导效率提高了14倍。这些数据表明,背景特异性肽展示文库可能允许选择兼容的肽配体,以便功能性地转化为用于重新靶向的病毒载体。

相似文献

2
Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob.
Gene Ther. 2007 Oct;14(20):1448-60. doi: 10.1038/sj.gt.3303007. Epub 2007 Aug 16.
6
Peptide targeting of adenoviral vectors to augment tumor gene transfer.
Cancer Gene Ther. 2012 Jul;19(7):476-88. doi: 10.1038/cgt.2012.23. Epub 2012 May 18.
7
Fiber-mosaic adenovirus as a novel approach to design genetically modified adenoviral vectors.
Virus Res. 2004 Sep 15;105(1):35-46. doi: 10.1016/j.virusres.2004.04.012.
10

引用本文的文献

1
Targeting Drug Delivery System to Skeletal Muscles: A Comprehensive Review of Different Approaches.
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13691. doi: 10.1002/jcsm.13691.
2
Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles to cystic fibrosis lung epithelia.
Mol Ther Nucleic Acids. 2024 Oct 28;35(4):102375. doi: 10.1016/j.omtn.2024.102375. eCollection 2024 Dec 10.
3
Strategies for Modifying Adenoviral Vectors for Gene Therapy.
Int J Mol Sci. 2024 Nov 20;25(22):12461. doi: 10.3390/ijms252212461.
4
Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity.
Cancers (Basel). 2020 Jun 9;12(6):1504. doi: 10.3390/cancers12061504.
5
Improving Molecular Therapy in the Kidney.
Mol Diagn Ther. 2020 Aug;24(4):375-396. doi: 10.1007/s40291-020-00467-6.
6
Retargeting adenoviruses for therapeutic applications and vaccines.
FEBS Lett. 2020 Jun;594(12):1918-1946. doi: 10.1002/1873-3468.13731. Epub 2020 Feb 3.
7
Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display.
J Nanobiotechnology. 2018 Aug 30;16(1):61. doi: 10.1186/s12951-018-0388-4.
8
Retargeted and detargeted adenovirus for gene delivery to the muscle.
Virology. 2018 Jan 15;514:118-123. doi: 10.1016/j.virol.2017.10.005. Epub 2017 Nov 22.
9
Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.
Hum Gene Ther. 2015 Dec;26(12):786-800. doi: 10.1089/hum.2015.107. Epub 2015 Oct 15.
10
Refactored M13 bacteriophage as a platform for tumor cell imaging and drug delivery.
ACS Synth Biol. 2012 Dec 21;1(12):576-582. doi: 10.1021/sb300052u. Epub 2012 Sep 24.

本文引用的文献

1
Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombination.
Hum Gene Ther. 2004 Nov;15(11):1125-30. doi: 10.1089/hum.2004.15.1125.
2
A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1.
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6188-93. doi: 10.1073/pnas.0400542101. Epub 2004 Apr 12.
4
Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification.
Mol Ther. 2003 Oct;8(4):688-700. doi: 10.1016/s1525-0016(03)00213-2.
5
General strategy for broadening adenovirus tropism.
J Virol. 2003 Oct;77(20):11094-104. doi: 10.1128/jvi.77.20.11094-11104.2003.
9
Phage display of adenovirus type 5 fiber knob as a tool for specific ligand selection and validation.
J Virol. 2001 Aug;75(15):7107-13. doi: 10.1128/JVI.75.15.7107-7113.2001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验